WHY CHOOSE ALIV

• ICU and pediatric-trained clinical staff.
• Founded by super-specialised doctors.
• Internationally sourced, pharmaceutical-grade compounds.
• Pioneers in regenerative medicine since 2015.
• Personalised programme design for your phenotype, biomarkers and existing medications.

HOW IT WORKS

Metabolic syndrome is not a single disease. It is a disease process with multiple converging drivers: insulin resistance, visceral adipose tissue acting as a hormonally active organ, chronic low-grade inflammation, mitochondrial dysfunction and behavioural inputs sustaining all of the above.

Layer 1: ALIV Cardiometabolic Foundation.

Microdose Tirzepatide (meaningful metabolic effects at more tolerable doses than full GLP-1 weight-loss protocols), microdose NAD+ (mitochondrial energetics and metabolic flexibility), Trim & Tone IV (L-Carnitine and methylated B-complex for fat metabolism).

Layer 2: Tesamorelin (visceral fat).

A GHRH analogue that selectively reduces visceral adipose tissue, the depot most strongly associated with metabolic and cardiovascular risk. Added where visceral fat is a dominant feature.

Layer 3: AOD-9604 and MOTS-c (selective).

AOD-9604 (GH fragment with selective lipolytic activity), MOTS-c (mitochondrially-encoded peptide with effects on insulin sensitivity in research models). Emerging additions; evidence preliminary; selective use.

Layer 4: Diagnostic Precision.

Beyond standard fasting glucose: HOMA-IR, full lipid panel including ApoB and Lp(a), hs-CRP, HbA1c, liver enzymes, FibroScan where indicated, body composition, and red-flag screening for cardiology referral.

THE LIFESTYLE LAYER

No peptide, GLP-1 or IV compensates for the daily inputs that create or sustain metabolic syndrome.

• Nutrition targeting insulin resistance: adequate protein, whole-food carbohydrates, lower glycaemic load, structured meal timing. Common supplements: Magnesium, Vitamin D, Omega-3, NAC, NMN, CoQ10, L-Carnitine.
• Structured training: resistance training is non-negotiable for insulin sensitivity and glycaemic control. Aerobic conditioning particularly valuable for NAFLD.
• Sleep, stress, alcohol, ultra-processed food: sleep deprivation is directly insulinogenic; cortisol drives visceral fat; alcohol and ultra-processed food drive hepatic fat.

PROTOCOL-RELATED FAQ

Q. How is this different from the Tier 1 Metabolic Reset?

A. Tier 1 addresses metabolic inflexibility and weight as primary drivers, appropriate for earlier-stage dysfunction. Advanced Metabolic Reset is for established disease: formal metabolic syndrome criteria, insulin resistance, NAFLD or T2D with continued risk.

Q. I am already on diabetes, BP and cholesterol medications. Is this for me?

A. Yes, if anything, you are a central candidate. The goal is not to replace these medications; it is to modify the underlying disease trajectory so that medication needs may eventually reduce, in coordination with your specialists.

Q. Can this reverse fatty liver (NAFLD)?

A. Meaningful NAFLD improvement is achievable for many clients with comprehensive intervention: weight and visceral fat reduction, insulin sensitisation, dietary change, exercise and Tesamorelin. Advanced fibrotic disease is harder to reverse.

Q. Can Type 2 diabetes be reversed?

A. T2D is potentially reversible for many clients, particularly when caught earlier (shorter duration, lower HbA1c, retained beta-cell function). Achievable: HbA1c below the diabetic threshold, medication reduction (specialist-directed), insulin resistance gains. Long-standing diabetes with significant beta-cell loss is harder to fully reverse. Never stop diabetes medication unilaterally.

Q. Who should not do this protocol?

A. Type 1 diabetes; active untreated cardiovascular events; active serious illness; pregnancy or breastfeeding; clients seeking to bypass appropriate specialist medical management.

Diabetes Reversal and Metabolic Syndrome Treatment in India

India is the global epicentre of metabolic syndrome, with around 30% of adults affected. ALIV's Advanced Metabolic Reset Protocol is a physician-supervised, integrative programme for adults with established cardiometabolic disease. Doctor-led at Pune and Mumbai.

What the Advanced Metabolic Reset Includes

The ALIV cardiometabolic foundation (microdose Tirzepatide, microdose NAD+, Trim & Tone IV), Tesamorelin for visceral fat where indicated, AOD-9604 and MOTS-c for selected cases, and a diagnostic backbone.

The Skinny-Fat Indian Phenotype

South Asian adults accumulate central adiposity at significantly lower BMIs than European populations. Normal-BMI Indians can have elevated visceral fat, insulin resistance and dyslipidaemia. Standard BMI screening misses this picture.

Who Should Consider This Protocol

Adults with formal metabolic syndrome criteria, insulin resistance, NAFLD, T2D with continued risk despite medication, GLP-1 plateau, or the skinny-fat Indian phenotype.

Why Choose ALIV for Cardiometabolic Care in India

Doctor-led, coordinated with your diabetologist or cardiologist, regenerative medicine team active since 2015.